[go: up one dir, main page]

ES2051864T3 - Un procedimiento para preparar una composicion farmaceutica con actividad anti-cancer. - Google Patents

Un procedimiento para preparar una composicion farmaceutica con actividad anti-cancer.

Info

Publication number
ES2051864T3
ES2051864T3 ES88310908T ES88310908T ES2051864T3 ES 2051864 T3 ES2051864 T3 ES 2051864T3 ES 88310908 T ES88310908 T ES 88310908T ES 88310908 T ES88310908 T ES 88310908T ES 2051864 T3 ES2051864 T3 ES 2051864T3
Authority
ES
Spain
Prior art keywords
preparing
procedure
pharmaceutical composition
cancer activity
benzylidene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88310908T
Other languages
English (en)
Inventor
Bernt Borretzen
Rolf Olaf Larsen
John Michael Dornish
Reidar Oftebro
Erik Olai Pettersen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Norsk Hydro ASA
Original Assignee
Norsk Hydro ASA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norsk Hydro ASA filed Critical Norsk Hydro ASA
Application granted granted Critical
Publication of ES2051864T3 publication Critical patent/ES2051864T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)

Abstract

EL USO DE ACIDO L-ASCORBICO, O DE UNA SAL FARMACEUTICAMENTE ACEPTABLE DE EL, EN COMBINACION CON ACIDO 5,6-O-BENCILIDENO-LASCORBICO CON DEUTERIO AL MENOS EN LA POSICION 1 ALDEHIDO DE LA MITAD DEL BENCILIDENO, O UNA SAL FARMACEUTICAMENTE ACEPTABLE DE TALES ACIDOS, PRODUCE UNA CITOTOXICIDAD SINERGISTICAMENTE MEJORADA SOBRE LAS CELULAS DE CANCER HUMANO.
ES88310908T 1988-11-18 1988-11-18 Un procedimiento para preparar una composicion farmaceutica con actividad anti-cancer. Expired - Lifetime ES2051864T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP88310908A EP0369079B1 (en) 1988-11-18 1988-11-18 Pharmaceutical compositions with anti-cancer activity and method for the treatment of cancer

Publications (1)

Publication Number Publication Date
ES2051864T3 true ES2051864T3 (es) 1994-07-01

Family

ID=8200292

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88310908T Expired - Lifetime ES2051864T3 (es) 1988-11-18 1988-11-18 Un procedimiento para preparar una composicion farmaceutica con actividad anti-cancer.

Country Status (6)

Country Link
EP (1) EP0369079B1 (es)
AT (1) ATE79750T1 (es)
DE (1) DE3874142T2 (es)
ES (1) ES2051864T3 (es)
GB (1) GB2208798B (es)
GR (1) GR3005531T3 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4427690A1 (de) * 1994-08-04 1996-02-08 Bogdahn Ulrich Prof Deuterium enthaltende pharmazeutische Zusammensetzung als Zytostatikum oder Tumor-Therapeutikum
DE19603477A1 (de) * 1996-01-31 1997-08-07 Klaus Dr Med Reuter Tumormittel
ATE401071T1 (de) * 1999-08-30 2008-08-15 Ester C Company Verwendungen und zusammensetzungen für selektive krebs-chemotherapie
EP4129283A4 (en) * 2020-03-31 2024-04-24 Natural Medicine Institute of Zhejiang Yangshengtang Co., Ltd. PHARMACEUTICAL ASSOCIATION AND ITS USE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60139619A (ja) * 1983-12-27 1985-07-24 Mutsuyuki Kochi Ｏ−ベンジリデン−アスコルビン酸又はその塩よりなる抗腫瘍剤
EP0249632A4 (en) * 1985-12-05 1988-06-20 American Biotechnology ATHRACYCLINE TYPE OF ANTITUARY WITH L-ASCORBIC ACID.

Also Published As

Publication number Publication date
ATE79750T1 (de) 1992-09-15
DE3874142D1 (de) 1992-10-01
DE3874142T2 (de) 1993-01-14
GB2208798A (en) 1989-04-19
EP0369079B1 (en) 1992-08-26
GR3005531T3 (es) 1993-06-07
EP0369079A1 (en) 1990-05-23
GB2208798B (en) 1991-06-05
GB8719670D0 (en) 1987-09-30

Similar Documents

Publication Publication Date Title
ATA195588A (de) Epipodophyllotoxinglucosid-4'-phosphat-derivate deren herstellung, sowie pharmazeutische zusammensetzungen hierzu
ES2084579T3 (es) Uso de buspirona en la preparacion de una composicion farmaceutica para el tratamiento del abuso del alcohol.
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
SE8402560D0 (sv) Farmaceutisk komposition
DE3863963D1 (de) Pharmazeutische zusammensetzungen.
CA2093806A1 (en) Method of treating or preventing type 1 diabetes by oral administration of insulin
IE780643L (en) THERAPEUTIC APPLICATION OF d, 1-CARNITINE DERIVITIVES
DE3868986D1 (de) Pharmazeutische zusammensetzungen.
IT1231434B (it) Composizione farmaceutica endovenosa e procedimento per la sua preparazione.
CA2009593A1 (en) Medicament containing dihydrolipoic acid as active substance
IT1229562B (it) Composizioni farmaceutiche antivirali ed immunostimolanti e procedimento per la loro preparazione.
ES2020171T3 (es) Eteres de 1-bencil-3-hidroximetilindazol con 2-hidroxiacidos alifaticos.
ATE22532T1 (de) Pharmazeutische zusammensetzung.
CA2042972A1 (en) Treatment of ocular hypertension with a synergistic combination for ocular administration
ZA892877B (en) Azelastine-containing medicaments with controlled release of the active substance
DE69004532D1 (de) Topisch anzuwendende Defibrotid enthaltende Arzneizubereitungen.
ES2037095T3 (es) Un procedimiento para preparar una composicion farmaceutica.
ES2051864T3 (es) Un procedimiento para preparar una composicion farmaceutica con actividad anti-cancer.
IT8722501A0 (it) Formulazioni farmaceutiche per somministrazione transdermica.
IT8920358A0 (it) Impiego di derivati della fosfatidil carnitina per la preparazione di composizioni farmaceutiche aventi attivita' nella terapia delle patologie dell'uomo associate con un danno neuronale.
AU536582B2 (en) Plenylpiperazine derivatives of 1,3,4-oxiadiazolylphends
DE3866789D1 (de) Pharmazeutische zusammensetzungen.
IT8821570A0 (it) Impiego di derivati adenosinici per la preparazione di composizioni farmaceutiche aventi attivita' immunostimolante.
IT1224250B (it) Associzione del depiprazolo con la morfina
RU93052408A (ru) Ациламино-алкилиден-гидрокси-бис-фосфоновые кислоты, способ их получения, фармацевтическая композиция

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 369079

Country of ref document: ES